tPA — Drug Target

All drugs that target tPA — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

tissue plasminogen activator · Thrombolytic · Fibrinolytic

Phase 3 pipeline (2)

• Standard-dose intravenous tenecteplase · The George Institute · tissue plasminogen activator · Cardiovascular
  Tenecteplase is a tissue plasminogen activator that works by catalyzing the conversion of plasminogen to plasmin, resulting in the breakdown of blood clots.
• Standard-dose rtPA · The George Institute · Thrombolytic · Cardiovascular
  Standard-dose rtPA works by dissolving blood clots to restore blood flow to the brain.

Phase 2 pipeline (1)

• Alteplase for Injection · Angde Biotech Pharmaceutical Co., Ltd. · Fibrinolytic · Cardiovascular
  Alteplase for Injection is a tissue plasminogen activator that works by dissolving blood clots.